James Glover, Charles Slacik, Ronni Sherman, Craig Venter, Claire Fraser-Liggett, Robert Strausberg, Eric Eisenstadt, Marvin Frazier, Yu-Hui Rogers | GenomeWeb
Anadys Pharmaceuticals has named James Glover chief financial officer and senior vice president of operations, effective immediately. Glover comes to Anadys from Beckman Coulter, where he was chief financial officer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.